[Federal Register Volume 83, Number 143 (Wednesday, July 25, 2018)]
[Notices]
[Page 35287]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-15884]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) will convene a 
meeting of the Advisory Committee on the Medical Uses of Isotopes 
(ACMUI) on September 20-21, 2018. Tentative agenda items to be 
discussed during the public session include: (1) Medical-related 
events; (2) an update on nursing mother guidelines; (3) licensing of 
thorium-227 chloride; (4) an update on the yttrium-90 microspheres 
licensing guidance revision; and (5) status of the NRC's training and 
experience (T&E) evaluation and stakeholder outreach plans for T&E. The 
agenda is subject to change. The current agenda and any updates will be 
available at http://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2018.html or may be requested by emailing Ms. Lisa Dimmick at 
the contact information below.
    Purpose: Discuss issues related to 10 CFR part 35, Medical Use of 
Byproduct Material.
    Date and Time for Open Sessions: September 20, 2018, from 8:30 a.m. 
to 3:00 p.m. and September 21, 2018, from 8:30 a.m. to 3:30 p.m. 
Eastern Standard Time.
    Date and Time for Closed Sessions: September 20, 2018, from 8:00 
a.m. to 8:30 a.m. and 3:30 p.m. to 5:00 .pm.
    Address for Public Meeting: U.S. Nuclear Regulatory Commission, One 
White Flint North Building, Commission Hearing Room, 11545 Rockville 
Pike, Rockville, Maryland 20852.
    Public Participation: Any member of the public who wishes to 
participate in the meeting in person or via phone should contact Ms. 
Dimmick using the information below. The meeting will also be webcast 
live at https://video.nrc.gov/.
    Contact Information: Lisa Dimmick, email: [email protected], 
telephone: (301) 415-0694.

Conduct of the Meeting

    Christopher J. Palestro, M.D. will chair the meeting. Dr. Palestro 
will conduct the meeting in a manner that will facilitate the orderly 
conduct of business. The following procedures apply to public 
participation in the meeting:
    1. Persons who wish to provide a written statement should submit an 
electronic copy to Ms. Dimmick using the contact information listed 
above. All submittals must be received by September 17, 2018, three 
business days before the meeting, and must pertain to the topics on the 
agenda for the meeting.
    2. Questions and comments from members of the public will be 
permitted during the meeting, at the discretion of the Chairman.
    3. The draft transcript and meeting summary will be available on 
ACMUI's website http://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2018.html on or about November 2, 2018.
    4. Persons who require special services, such as those for the 
hearing impaired, should notify Ms. Dimmick of their planned 
attendance.
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in title 
10 of the Code of Federal Regulations, part 7.

    Dated at Rockville, Maryland, this 20th day of July 2018.

    For the Nuclear Regulatory Commission.
Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2018-15884 Filed 7-24-18; 8:45 am]
 BILLING CODE 7590-01-P